Osaic Holdings’s Nuvation Bio NUVB Stock Holding History

Osaic Holdings’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Buy	37,507 +431	+1%	+$2.4K	﹤0.01%	4329
2025 Q4	$332K	Buy	37,076 +35,519	+2,281%	+$220K	﹤0.01%	3704
2025 Q3	$5.58K	Sell	1,557 -1,152	-43%	-$3.14K	﹤0.01%	6689
2025 Q2	$5.28K	Buy	2,709 +602	+29%	+$1.25K	﹤0.01%	6515
2025 Q1	$3.71K	Buy	2,107 +740	+54%	+$1.68K	﹤0.01%	6335
2024 Q4	$3.64K	Sell	1,367 -52	-4%	-$134	﹤0.01%	6357
2024 Q3	$3.25K	Sell	1,419 -4,081	-74%	-$12.4K	﹤0.01%	6402
2024 Q2	$16.1K	Buy	5,500 +5,000	+1,000%	+$15.3K	﹤0.01%	5490
2024 Q1	$1.82K	Hold	500	–	–	﹤0.01%	6505
2023 Q4	$755	Hold	500	–	–	﹤0.01%	6830
2023 Q3	$670	Hold	500	–	–	﹤0.01%	6929
2023 Q2	$900	Hold	500	–	–	﹤0.01%	6910
2023 Q1	$830	Hold	500	–	–	﹤0.01%	7015
2022 Q4	$1K	Buy	+500	New	+$1.01K	﹤0.01%	6916

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's NUVB Position: Q1 2026 in Review

Osaic Holdings increased its Nuvation Bio (NUVB) stake by 1.2% in Q1 2026, buying an estimated $2.4K and bringing the position to 37,507 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #4329.

Osaic Holdings first reported a position in NUVB in Q4 2022 and has held it in 14 quarters since. The position peaked at $332K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Osaic Holdings held 37,507 shares of Nuvation Bio worth $161K as of Q1 2026.
Osaic Holdings bought 431 Nuvation Bio shares in Q1 2026, an estimated $2.4K.
Nuvation Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4329 holding.
Osaic Holdings first reported a position in Nuvation Bio in Q4 2022 and has held it in 14 quarters since.
Osaic Holdings's Nuvation Bio position peaked at $332K in Q4 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.